Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coagulo has developed a rapid point-of-care diagnostic device that delivers clinically actionable results within 10 minutes using just drops of whole blood. The system can simultaneously perform over 20 tests to pinpoint the exact coagulation factor deficiency or inhibition, providing personalized diagnosis and management for all coagulation-related diseases. The company has received $6.5M in financing to accelerate development and was awarded an NSF SBIR grant[5]. Clinical validation activities are ongoing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coagulo Medical Technologies.